Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Direkt zur Navigaton springen.
Direkt zum Inhalt springen.

Druckansicht.
English.
Kontakt.
Datenerfassung.
Start.
Open Access.

Navigation/Suche

Forscher*innen.
Institutionen.
Projekte.
Publikationen.
Partner.
Geldgeber.
Ausstattung.
Knowhow.
Forschungsfelder.

Gewählte Publikation:

Stander, S; Yosipovitch, G; Legat, FJ; Reich, A; Paul, C; Simon, D; Naldi, L; Silverberg, JI; Gharib, R; Fleischer, A; Laquer, VT; Ahmad, F; Jabbar-Lopez, Z; Piketty, C; Kwatra, SG.
Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2)
BRIT J DERMATOL. 2023; 188: ljad162056 Doi: 10.1093/bjd/ljad162.056 [Poster]
Web of Science FullText FullText_MUG

Autor*innen der Med Uni Graz:: Legat Franz
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Find related publications in this database (Keywords): prurigo nodularis; nemolizumab; interleukin-31; interleukin-31 receptor alpha; pruritus